OLMA
Olema Pharmaceuticals, Inc.Company with tickers: OLMA
CIK
1750284
CUSIP
68062P106
Shares Outstanding
87,347,471
13F Activity (30d)
142 filings
140 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-05-26 | — | |
| 8-K | 2026-05-21 | — | |
| 8-K | 2026-05-12 | — | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 8-K | 2026-05-01 | 2026-04-27 | |
| 8-K | 2026-04-29 | 2026-04-27 | |
| 8-K | 2026-03-16 | — | |
| 10-K | 2026-03-16 | 2025-12-31 | |
| 8-K | 2026-01-30 | 2026-01-27 | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-11-19 | — | |
| 8-K | 2025-11-18 | — | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-11-10 | — | |
| 8-K | 2025-10-20 | 2025-10-18 | |
| 8-K | 2025-09-02 | — | |
| 10-Q | 2025-08-11 | 2025-06-30 | |
| 8-K | 2025-08-11 | — | |
| 8-K | 2025-06-13 | 2025-06-10 | |
| 8-K | 2025-05-13 | — | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| 10-K | 2025-03-18 | 2024-12-31 | |
| 8-K | 2025-03-18 | — | |
| 8-K | 2025-03-05 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2025-01-10 | — | |
| 8-K | 2024-12-10 | 2024-12-09 | |
| 8-K | 2024-12-02 | 2024-11-29 | |
| 8-K | 2024-11-12 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-09-27 | — | |
| 8-K | 2024-08-06 | — | |
| 10-Q | 2024-08-06 | 2024-06-30 | |
| 8-K | 2024-07-02 | 2024-06-28 | |
| 8-K | 2024-06-14 | 2024-06-13 | |
| 8-K | 2024-05-15 | — | |
| 8-K | 2024-05-08 | — | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| 10-K | 2024-03-11 | 2023-12-31 | |
| 8-K | 2024-03-11 | — | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2024-01-05 | — | |
| 8-K | 2023-12-06 | — | |
| 8-K | 2023-12-05 | — | |
| 10-Q | 2023-11-07 | 2023-09-30 | |
| 8-K | 2023-11-07 | — | |
| 8-K | 2023-10-23 | 2023-10-22 | |
| 8-K/A | 2023-10-18 | 2023-10-13 | |
| 8-K | 2023-10-17 | 2023-10-13 | |
| 8-K | 2023-10-10 | 2023-10-09 |
Showing 1–50 of 83 filings